NCT00867932View on ClinicalTrials.gov

Eculizumab Pharmacokinetics/Pharmacodynamics Study in Pediatric/Adolescent Paroxysmal Nocturnal Hemoglobinuria (PNH)

PHASE4CompletedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

October 2, 2009

Primary Completion Date

May 12, 2011

Study Completion Date

May 12, 2011

Conditions
Hemoglobinuria, Paroxysmal
Interventions
DRUG

Eculizumab

5 mg/mL solution in 5% Dextrose

Trial Locations (3)

32504

Pensacola

38105

Memphis

92868

Orange

Sponsors
All Listed Sponsors
lead

Alexion Pharmaceuticals, Inc.

INDUSTRY